 Anebulo Pharmaceuticals, Inc. ANEB announced financial results for the three months ended December 31, 2021 and recent updates. Q2 2022 Financial Highlights Operating expenses in the second quarter of fiscal 2022 were 1.1 million compared with 0.3 million in the same period in fiscal 2021. 